| Literature DB >> 25631792 |
Xin-Hui Qiu1, Ya-Feng Zhang1, Yu-Yan Chen1, Qiao Zhang1, Fu-Yi Chen2, Long Liu3, Jin-Yi Fan1, Kun Gao1, Xiao-Zhen Zhu1, Wei-Hong Zheng1, Hui-Lin Zhang1, Li-Rong Lin1, Li-Li Liu1, Man-Li Tong1, Chang-Gong Zhang4, Jian-Jun Niu5, Tian-Ci Yang6.
Abstract
We developed a new Boson chemiluminescence immunoassay (CIA) and evaluated its application with cross-sectional analyses. Our results indicated that the Boson CIA demonstrated strong discriminatory power in diagnosing syphilis and that it can be used as a first-line screening test for syphilis serodiagnosis using the European Centre for Disease Prevention and Control algorithm or as a confirmatory test when combined with a patient's clinical history.Entities:
Mesh:
Year: 2015 PMID: 25631792 PMCID: PMC4365203 DOI: 10.1128/JCM.00069-15
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948